Technical Analysis for QNRX - Quoin Pharmaceuticals, Ltd.

Grade Last Price % Change Price Change
D 0.76 1.51% 0.01
QNRX closed up 1.51 percent on Friday, November 1, 2024, on 4 percent of normal volume.
Earnings due: Nov 7
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Up Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 1.51%
Wide Bands Range Expansion -6.38%
Shooting Star Candlestick Bearish -13.85%
Wide Bands Range Expansion -13.85%
Wide Bands Range Expansion -13.72%
1,2,3 Pullback Bullish Bullish Swing Setup -6.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.14%
Calm After Storm Range Contraction -6.14%
NR7 Range Contraction -6.14%

   Recent Intraday Alerts

Alert Time
Down 3% about 18 hours ago
Possible NR7 about 19 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
Down 2 % about 21 hours ago
Down 1% about 21 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Founded in 2018 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Therapeutic Products Genodermatoses Epidermolysis Bullosa Netherton Syndrome Rare And Orphan Diseases

Is QNRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.18
52 Week Low 0.4772
Average Volume 3,299,028
200-Day Moving Average 1.09
50-Day Moving Average 0.64
20-Day Moving Average 0.70
10-Day Moving Average 0.81
Average True Range 0.13
RSI (14) 54.34
ADX 55.41
+DI 49.19
-DI 11.93
Chandelier Exit (Long, 3 ATRs) 1.19
Chandelier Exit (Short, 3 ATRs) 0.86
Upper Bollinger Bands 0.99
Lower Bollinger Band 0.40
Percent B (%b) 0.6
BandWidth 84.66
MACD Line 0.06
MACD Signal Line 0.06
MACD Histogram 0.0034
Fundamentals Value
Market Cap 748.71 Thousand
Num Shares 987 Thousand
EPS 1.38
Price-to-Earnings (P/E) Ratio 0.55
Price-to-Sales 0.00
Price-to-Book 0.45
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.87
Resistance 3 (R3) 0.87 0.83 0.85
Resistance 2 (R2) 0.83 0.80 0.83 0.84
Resistance 1 (R1) 0.79 0.79 0.81 0.79 0.84
Pivot Point 0.76 0.76 0.77 0.76 0.76
Support 1 (S1) 0.72 0.73 0.74 0.72 0.68
Support 2 (S2) 0.69 0.71 0.69 0.67
Support 3 (S3) 0.65 0.69 0.67
Support 4 (S4) 0.65